Literature DB >> 3778523

Denaturation of cytochrome P-450 by indomethacin and other non-steroidal anti-inflammatory drugs: evidence for a surfactant mechanism and a selective effect of a p-chlorophenyl moiety.

M Falzon, A Nielsch, M D Burke.   

Abstract

Indomethacin added to rat liver microsomes in vitro resulted in the denaturation of cytochrome P-450 to cytochrome P-420. This was NADPH independent, appeared to be non-enzyme mediated, did not involve free radicals or lipid peroxidation and was prevented by glycerol, butylated hydroxytoluene or SKF-525A. Indomethacin in vitro also caused a loss of cytochrome b5, NADH-cytochrome b5 reductase, NADPH-cytochrome c reductase and epoxide hydrolase activities, but an activation of UDP-glucuronyltransferase. Amongst a total of 22 non-steroidal anti-inflammatory drugs and derivatives there was a highly significant correlation between the extent of their denaturation of cytochrome P-450 and their surfactant potency. The results suggest that the denaturation of cytochrome P-450 by certain non-steroidal anti-inflammatory drugs was due to a detergent-like, membrane-perturbing action of the drugs and that in most cases the denaturation also involved a specific effect of a p-chlorophenyl moiety of the drug.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778523     DOI: 10.1016/0006-2952(86)90021-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Enhanced protein denaturation in indomethacin-treated cells.

Authors:  I Roussou; v T Nguyen; G N Pagoulatos; O Bensaude
Journal:  Cell Stress Chaperones       Date:  2000-01       Impact factor: 3.667

2.  Interactions between calvatic acid and related compounds with rat liver microsomes.

Authors:  A Miglietta; E Gadoni; M Buffa; A Olivero; L Gabriel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1995 Oct-Dec       Impact factor: 2.441

3.  Hepatic alterations in indomethacin-treated rabbits.

Authors:  G Martines; L Boiardi; L Butturini; S Bernardi; G Gelmini
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.